Company: ZLAB
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001704292-25-000024
Chunk: 36

Company: Zai Lab Ltd
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 1
Chunk 36
---
7 7 Additional paid-in capital3,327,557 3,264,295 Accumulated deficit(2,578,211)(2,453,083)Accumulated other comprehensive income39,645 50,515 Treasury Stock (at cost, 7,433,210 and 4,912,200 shares as of September 30, 2025 and December 31, 2024, respectively)(29,053)(20,836)Total shareholders’ equity759,945 840,898 Total liabilities and shareholders’ equity1,158,940 1,185,753 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

2

Zai Lab Limited 

Unaudited Condensed Consolidated Statements of Operations

(in thousands of $, except for number of shares and per share data) 

Three Months Ended September 30,Nine Months Ended September 30,Notes2025202420252024RevenuesProduct revenue, net7115,361 101,847 330,095 289,102 Collaboration revenue7734 418 2,464 816 Total revenues116,095 102,265 332,559 289,918 ExpensesCost of product revenue(46,764)(36,569)(128,219)(105,336)Cost of collaboration revenue(119)(348)(531)(433)Research and development(47,928)(65,982)(159,271)(182,252)Selling, general, and administrative(70,106)(67,219)(204,566)(216,123)Loss from operations(48,822)(67,853)(160,028)(214,226)Interest income8,345 9,029 25,794 28,017 Interest expenses(1,400)(745)(3,848)(1,350)Foreign currency gains 6,422 14,457 9,909 8,281 Other income (expense), net15(508)3,441 3,045 3,859 Loss before income tax (35,963)(41,671)(125,128)(175,419)Income tax expense8— — — — Net loss(35,963)(41,671)(125,128)(175,419)Loss per share - basic and diluted9(0.03)(0.04)(0.11)(0.18